NO903033L - Positive inotrope og lusitrope 3,5-dihydroimidazo(2,1-b-)kinazolin-2(1h)-on-derivater. - Google Patents

Positive inotrope og lusitrope 3,5-dihydroimidazo(2,1-b-)kinazolin-2(1h)-on-derivater.

Info

Publication number
NO903033L
NO903033L NO90903033A NO903033A NO903033L NO 903033 L NO903033 L NO 903033L NO 90903033 A NO90903033 A NO 90903033A NO 903033 A NO903033 A NO 903033A NO 903033 L NO903033 L NO 903033L
Authority
NO
Norway
Prior art keywords
6alkyl
hydrogen
cooch2conr
cooc1
4alkyl
Prior art date
Application number
NO90903033A
Other languages
English (en)
Other versions
NO903033D0 (no
NO173870C (no
NO173870B (no
Inventor
Eddy Jean Edgard Freyne
Alfons Herman Marg Raeymaekers
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO903033D0 publication Critical patent/NO903033D0/no
Publication of NO903033L publication Critical patent/NO903033L/no
Publication of NO173870B publication Critical patent/NO173870B/no
Publication of NO173870C publication Critical patent/NO173870C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0892—Compounds with a Si-O-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO903033A 1989-07-07 1990-07-06 Analogifremgnagsmaate for fremstilling av terapeutisk aktive 3,5-dihydroimidazo(2,1-b)binazolin-2(1h)-on-derivater NO173870C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89201810 1989-07-07
US38133889A 1989-07-18 1989-07-18

Publications (4)

Publication Number Publication Date
NO903033D0 NO903033D0 (no) 1990-07-06
NO903033L true NO903033L (no) 1991-01-08
NO173870B NO173870B (no) 1993-11-08
NO173870C NO173870C (no) 1994-02-16

Family

ID=26121192

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903033A NO173870C (no) 1989-07-07 1990-07-06 Analogifremgnagsmaate for fremstilling av terapeutisk aktive 3,5-dihydroimidazo(2,1-b)binazolin-2(1h)-on-derivater

Country Status (18)

Country Link
EP (1) EP0406958B1 (no)
JP (1) JPH0363277A (no)
KR (1) KR910002857A (no)
AT (1) ATE119902T1 (no)
AU (1) AU623539B2 (no)
CA (1) CA2020630A1 (no)
DE (1) DE69017773T2 (no)
DK (1) DK0406958T3 (no)
ES (1) ES2072373T3 (no)
FI (1) FI93361C (no)
HU (1) HUT55395A (no)
IE (1) IE65781B1 (no)
IL (1) IL94978A (no)
NO (1) NO173870C (no)
NZ (1) NZ234186A (no)
PH (1) PH27111A (no)
PT (1) PT94616B (no)
RU (1) RU2057753C1 (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120845A (en) * 1989-07-18 1992-06-09 Janssen Pharmaceutica N.V. Positive inotropic and lusitropic 3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one derivatives
JPH05271200A (ja) * 1991-05-22 1993-10-19 Egyt Gyogyszervegyeszeti Gyar ６，７−ジクロロ−１，５−ジヒドロ−イミダゾ〔２，１−ｂ〕キナゾリン−２〔３Ｈ〕−オンの製造方法
PH31245A (en) * 1991-10-30 1998-06-18 Janssen Pharmaceutica Nv 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives.
FR2689012A1 (fr) * 1992-03-27 1993-10-01 Beecham Laboratoires Utilisation de composés aryliques dans le traitement d'affections cardio-vasculaires.
TW593317B (en) * 1993-06-21 2004-06-21 Janssen Pharmaceutica Nv Positive cardiac inotropic and lusitropic pyrroloquinolinone derivatives
KR100347215B1 (ko) * 1994-03-07 2002-10-31 주식회사 삼영건설기술공사 고강도구조보강나선관
US6451807B1 (en) 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor
ES2246859T3 (es) 1999-05-28 2006-03-01 Virco Bvba Nuevos perfiles mutacionales en la transcriptasa inversa del vih-1 correlacionadas con una resistencia fenotipica a farmacos.
EP1356082A2 (en) 2000-10-20 2003-10-29 Virco Bvba Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
ATE411996T1 (de) * 2002-09-30 2008-11-15 Bayer Healthcare Ag Kondensierte azolpyrimidinderivate
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7700608B2 (en) 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US8426429B2 (en) 2004-08-06 2013-04-23 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8436006B2 (en) * 2004-08-06 2013-05-07 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
US8383637B2 (en) 2004-08-06 2013-02-26 Jansssen Pharmaceutica N.V. 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
EP1966198B1 (en) 2005-10-25 2011-03-16 Janssen Pharmaceutica NV 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of beta-secretase (bace)
JP2009514969A (ja) 2005-11-09 2009-04-09 コンビナトアールエックス インコーポレーティッド 医学的状態を治療するための方法、組成物、およびキット
US7776882B2 (en) 2006-02-06 2010-08-17 Baxter Ellen W 2-amino-3,4-dihydro-quinoline derivatives useful as inhibitors of β-secretase (BACE)
US7868022B2 (en) 2006-02-06 2011-01-11 Janssen Pharmaceutica Nv 2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE)
US7932261B2 (en) 2006-02-06 2011-04-26 Janssen Pharmaceutica Nv Macrocycle derivatives useful as inhibitors of β-secretase (BACE)
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
WO2009097278A1 (en) 2008-01-28 2009-08-06 Janssen Pharmaceutica N.V. 6-SUBSTITUTED-THIO-2-AMINO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE)
EP2240472B1 (en) 2008-01-29 2012-11-21 Janssen Pharmaceutica NV 2-amino-quinoline derivatives useful as inhibitors of beta-secretase (bace)
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808953D0 (en) * 2008-05-16 2008-06-25 Shire Llc substituted quinazolines
GB0808950D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
DK2681236T3 (en) 2011-03-01 2018-04-16 Synergy Pharmaceuticals Inc PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP4706758A3 (en) 2019-05-21 2026-05-06 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides

Also Published As

Publication number Publication date
RU2057753C1 (ru) 1996-04-10
DK0406958T3 (da) 1995-04-03
EP0406958B1 (en) 1995-03-15
IE65781B1 (en) 1995-11-15
DE69017773T2 (de) 1995-07-13
FI93361C (fi) 1995-03-27
EP0406958A3 (en) 1991-09-25
NO903033D0 (no) 1990-07-06
HUT55395A (en) 1991-05-28
DE69017773D1 (de) 1995-04-20
FI903428A0 (fi) 1990-07-06
HU904118D0 (en) 1990-12-28
NO173870C (no) 1994-02-16
AU5879890A (en) 1991-01-10
ATE119902T1 (de) 1995-04-15
IL94978A (en) 1994-06-24
FI93361B (fi) 1994-12-15
IL94978A0 (en) 1991-06-10
KR910002857A (ko) 1991-02-26
PH27111A (en) 1993-03-16
NO173870B (no) 1993-11-08
JPH0363277A (ja) 1991-03-19
AU623539B2 (en) 1992-05-14
EP0406958A2 (en) 1991-01-09
ES2072373T3 (es) 1995-07-16
NZ234186A (en) 1991-10-25
PT94616A (pt) 1991-03-20
IE902469A1 (en) 1991-02-13
CA2020630A1 (en) 1991-01-08
PT94616B (pt) 1997-02-28

Similar Documents

Publication Publication Date Title
NO903033L (no) Positive inotrope og lusitrope 3,5-dihydroimidazo(2,1-b-)kinazolin-2(1h)-on-derivater.
AU588890B2 (en) (4-Piperidinylmethyl and - hetero) Purines
CA2305612A1 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
AU630575B2 (en) Benzodiazepine derivatives
NO302821B1 (no) Aminobenzosyrederivat, preparat omfattende derivatet og anvendelse av derivatet
NO176608C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-piperidinylindazol-derivater